SPCC1322.03 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies are Y-shaped glycoproteins consisting of two heavy chains and two light chains, connected by disulfide bonds. Their structure includes:

  • Variable regions (VH/VL): Bind antigens via complementarity-determining regions (CDRs) .

  • Constant regions (CH/CL): Facilitate interactions with immune effector cells (e.g., via Fc receptors) .

Key functions:

  • Neutralization (blocking pathogen entry or toxin activity) .

  • Opsonization (marking pathogens for phagocytosis) .

  • Complement activation (lysing pathogens) .

Potential Research Directions for SPCC

If SPCC1322.03 is under development, its characterization would likely involve:

  • Target antigen identification: Determining its epitope (e.g., viral spike protein, tumor-associated antigen) .

  • Isotype classification: IgG, IgM, or engineered variants (e.g., SC27 for COVID-19) .

  • Therapeutic applications: Oncology (e.g., ADCC-enhanced antibodies like BMS-986012) , infectious diseases, or autoimmune conditions.

COVID-19 Broad-Spectrum Antibodies

  • SC27 (Texas Biomedical Research Institute):

    • Targets conserved regions of SARS-CoV-2 spike protein, neutralizing all variants tested .

    • Mechanism: Blocks ACE2 binding and binds cryptic sites .

  • ADG-2 (SARS-CoV-2/related viruses):

    • Cross-neutralizes SARS-CoV, SHC014, and WIV-1 with IC50 ≤ 8 ng/mL .

    • Provides prophylactic protection in mouse models .

Engineered Antibodies

  • BMS-986012 (Small-cell lung cancer):

    • Defucosylated Fc region enhances ADCC and CDC .

    • Exhibits synergy with checkpoint inhibitors .

Recommendations for Further Investigation

  1. Literature Review: Search PubMed/PatentScope for SPCC1322.03 alongside terms like "monoclonal antibody," "epitope," or "therapeutic target."

  2. Industrial Partnerships: Contact biotech firms (e.g., Biocare Medical ) or academic institutions (e.g., Texas Biomed ) for proprietary data.

  3. Preclinical Models: Test SPCC1322.03 in in vitro neutralization assays or in vivo efficacy studies using relevant disease models .

Data Gaps

  • No peer-reviewed publications, clinical trial records, or commercial product listings for SPCC1322.03 are available in the provided sources.

  • Potential reasons for obscurity:

    • Early-stage development.

    • Non-disclosure agreements (NDAs) restricting data sharing.

    • Typographical error in the compound name.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC1322.03 antibody; Uncharacterized membrane protein C1322.03 antibody
Target Names
SPCC1322.03
Uniprot No.

Target Background

Database Links
Protein Families
Transient receptor potential (TRP) ion channel family
Subcellular Location
Cytoplasm. Golgi apparatus membrane; Multi-pass membrane protein.

Q&A

What is SPCC1322.03 protein and what cellular functions has it been associated with?

SPCC1322.03 (UniProt: O94543) is a protein found in Schizosaccharomyces pombe (fission yeast strain 972/ATCC 24843). Research indicates it plays a role in DNA repair complexes. Based on studies of the related protein SPCC1322.02 (later named Pxd1), SPCC1322.03 may be involved in similar cellular processes involving structure-specific nucleases .

The protein was identified in protein complex studies showing interactions with Rad16-Swi10-Saw1 and Dna2-Cdc24, suggesting a role in DNA damage response pathways . Understanding this protein contributes to fundamental knowledge about DNA repair mechanisms in eukaryotes.

Which experimental techniques can effectively employ SPCC1322.03 Antibody?

SPCC1322.03 Antibody is suitable for multiple experimental applications:

  • Immunoprecipitation (IP): For protein complex isolation as demonstrated in studies of related proteins in S. pombe

  • Western blotting: For detection and quantification of SPCC1322.03 expression levels

  • Immunohistochemistry (IHC): For localization studies, though optimization is required for fission yeast

  • Chromatin immunoprecipitation (ChIP): For studying DNA-protein interactions

Methodology should be optimized based on research by Ippolito et al. on antibody validation in complex systems .

How should researchers assess SPCC1322.03 Antibody specificity?

Antibody specificity assessment should include:

  • Knockout/knockdown controls: Testing antibody reactivity in SPCC1322.03-deficient strains

  • Western blot validation: Confirming single band at expected molecular weight

  • Cross-reactivity testing: Checking reactivity against related Schizosaccharomyces species proteins

  • IP-Mass spectrometry validation: Confirming target enrichment

As demonstrated in immunohistochemical studies, antibody clone selection significantly impacts specificity - a critical consideration when working with structurally similar proteins in yeast .

How can researchers optimize immunoprecipitation protocols for studying SPCC1322.03 protein interactions?

Optimize IP protocols through the following methodology:

  • Cell lysis optimization:

    • Use glass bead beating in lysis buffer (50 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 10% glycerol, 0.05% NP-40)

    • Include protease inhibitors (1 mM PMSF, 1× Roche Protease Inhibitor Cocktail)

    • Maintain cold temperatures throughout to preserve interactions

  • Antibody coupling:

    • Pre-clear lysate with non-specific IgG

    • Use 5-10 μg antibody per 50 OD600 units of cells

    • Couple to appropriate beads (Protein A/G or directly conjugated beads)

  • Washing conditions:

    • Test stringency gradient (salt concentration 150-500 mM)

    • Determine optimal detergent concentration (0.05-0.5% NP-40)

  • Elution strategies:

    • Compare acidic glycine elution vs. boiling in sample buffer

    • For native complex isolation, consider competitive peptide elution

For research involving DNA repair complexes, the protocol used by researchers studying Pxd1-associated proteins provides a validated methodology .

What experimental design best reveals SPCC1322.03's role in DNA repair mechanisms?

A comprehensive experimental approach should include:

  • Genetic interaction studies:

    • Create SPCC1322.03 deletion strains

    • Construct double mutants with known DNA repair genes (e.g., rad16Δ, swi10Δ)

    • Assess synthetic lethality/sickness phenotypes

  • DNA damage sensitivity assays:

    • Expose mutants to various DNA damaging agents (UV, MMS, camptothecin)

    • Measure survival rates and recovery kinetics

    • Compare with phenotypes of related mutants (e.g., pxd1Δ)

  • Protein complex analysis:

    • Perform reciprocal IPs with Rad16-Swi10-Saw1 and Dna2-Cdc24 components

    • Use cross-linking mass spectrometry (CXMS) for interaction sites

    • Apply yeast two-hybrid analysis for direct interaction mapping

  • Functional complementation:

    • Test if SPCC1322.03 can restore function in related gene mutants

    • Construct chimeric proteins to identify functional domains

This approach successfully identified functional relationships between Pxd1 and structure-specific nucleases in S. pombe .

How should researchers interpret changes in SPCC1322.03 localization following DNA damage?

Interpretation should consider:

  • Quantitative analysis:

    • Measure nuclear vs. cytoplasmic signal intensities

    • Track protein localization over time using time-lapse microscopy

    • Quantify co-localization with DNA damage markers (e.g., γH2A.X foci)

  • Controls for interpretation:

    • Include untreated controls at all time points

    • Compare with known DNA repair factors' localization patterns

    • Use multiple DNA damaging agents to distinguish pathway-specific responses

  • Localization dynamics analysis:

    • Determine recruitment kinetics to damage sites

    • Analyze residence time using FRAP (Fluorescence Recovery After Photobleaching)

    • Assess dependency on cell cycle phase

  • Mutation impact assessment:

    • Test the effect of site-directed mutations (similar to A155D/E172A in Pxd1)

    • Determine if phosphorylation or other modifications affect localization

When analyzing relocalization, compare with patterns observed for Pxd1, which shows damage-dependent interactions with repair complexes .

What are common technical challenges when using SPCC1322.03 Antibody in Western blots?

Common challenges and solutions include:

  • High background issues:

    • Increase blocking stringency (5% BSA or milk in TBST)

    • Optimize antibody dilution (typically test 1:500 to 1:10,000)

    • Extend washing steps (4-5 times, 10 minutes each)

    • Use freshly prepared buffers

  • Weak or absent signal:

    • Increase protein loading (20-40 μg total protein)

    • Optimize extraction method for nuclear proteins

    • Reduce transfer time/voltage for high molecular weight proteins

    • Test alternative membrane types (PVDF vs. nitrocellulose)

    • Consider using signal enhancement systems

  • Multiple bands or non-specific binding:

    • Increase salt concentration in wash buffer (up to 500 mM NaCl)

    • Pre-adsorb antibody with non-specific proteins

    • Use knockout/knockdown controls to identify specific bands

    • Optimize primary antibody incubation (4°C overnight vs. room temperature)

These approaches align with methodologies used in successful detection of related proteins in similar systems .

How can researchers validate SPCC1322.03 Antibody for specific experimental applications?

Comprehensive validation includes:

  • Application-specific validation:

    ApplicationValidation Method
    Western BlotConfirm single band at expected MW; test in KO strain
    IPMass spectrometry of pulled-down proteins; reciprocal IP
    IHCCompare with fluorescent protein fusion localization
    ChIPCompare with known binding sites of interaction partners
  • Controls for validation:

    • Genetic knockouts or knockdowns

    • Competing peptide controls

    • Secondary antibody-only controls

    • Isotype controls

  • Cross-platform validation:

    • Confirm findings with orthogonal methods (e.g., validate IP results with yeast two-hybrid)

    • Compare with GFP-tagged protein behavior

    • Test multiple antibody clones if available

This validation approach follows best practices established for antibody validation in complex biological systems .

How should conflicting results between SPCC1322.03 Antibody and genetic studies be reconciled?

When antibody-based and genetic results conflict:

  • Technical assessment:

    • Evaluate antibody specificity using knockout controls

    • Consider epitope accessibility in different experimental conditions

    • Assess post-translational modifications that might affect antibody binding

    • Review buffer conditions that might disrupt protein interactions

  • Biological interpretation:

    • Consider redundant protein functions in genetic backgrounds

    • Evaluate potential adaptation mechanisms in knockout strains

    • Assess potential differences between acute (antibody-mediated) vs. chronic (genetic) loss of function

    • Investigate non-canonical functions that might be revealed by different approaches

  • Resolution strategies:

    • Perform domain-specific knockout studies

    • Use multiple antibodies targeting different epitopes

    • Apply complementary approaches like CRISPR interference or auxin-inducible degron tags

    • Develop functional assays to test specific hypotheses

This approach was effective in resolving apparently contradictory findings in studies of DNA repair factors in S. pombe .

How does SPCC1322.03 compare with its homologs in other yeast species?

Analysis should include:

  • Structural comparison:

    • Sequence alignment with homologs from related species

    • Domain architecture analysis

    • Conservation of key functional residues (similar to conserved residues A155 and E172 in Pxd1)

    • Phylogenetic analysis to determine evolutionary relationships

  • Functional conservation:

    • Complementation studies in different yeast species

    • Comparison of protein interaction networks

    • Assessment of DNA damage sensitivity phenotypes across species

    • Evaluation of subcellular localization patterns

  • Regulatory differences:

    • Promoter structure and regulation comparison

    • Analysis of post-translational modifications

    • Cell cycle-dependent expression patterns

    • Response to environmental stressors

This comparative approach has proven valuable in understanding the functional evolution of DNA repair factors in yeasts .

What protein-protein interactions can be reliably detected using SPCC1322.03 Antibody?

Based on studies of related proteins:

  • Established interaction partners:

    • Components of the Rad16-Swi10-Saw1 complex

    • Dna2-Cdc24 complex components

    • Potential interactions with DNA repair machinery

  • Interaction detection methodology:

    • Co-immunoprecipitation with stringent washing (0.1-0.3M NaCl)

    • Size exclusion chromatography to isolate intact complexes

    • Cross-linking prior to IP for transient interactions

    • Use of nuclease treatment to distinguish DNA-mediated from direct interactions

  • Validation of novel interactions:

    • Reciprocal co-IP with antibodies against potential partners

    • Yeast two-hybrid or split-fluorescent protein assays

    • In vitro binding assays with purified components

    • Functional studies to confirm biological relevance

This approach aligns with methods used to characterize the PXD complex in fission yeast .

How can researchers effectively use SPCC1322.03 Antibody in chromatin immunoprecipitation experiments?

Optimized ChIP methodology should include:

  • Crosslinking optimization:

    • Test formaldehyde concentration (0.5-3%)

    • Optimize crosslinking time (5-30 minutes)

    • Consider dual crosslinkers for protein-protein and protein-DNA interactions

  • Sonication parameters:

    • Determine optimal sonication conditions for S. pombe cells

    • Target fragment size of 200-500 bp

    • Verify fragmentation by agarose gel electrophoresis

  • Immunoprecipitation conditions:

    • Pre-clear chromatin with non-specific IgG

    • Use 2-10 μg antibody per sample

    • Include appropriate controls (IgG, input, non-target regions)

  • Data analysis considerations:

    • Normalize to input DNA

    • Include positive control regions (known binding sites of interaction partners)

    • Use appropriate statistical methods for peak calling

    • Consider integrating with other genomic datasets

This approach has been successfully applied to study chromatin-associated factors in yeast DNA repair .

How can SPCC1322.03 Antibody be utilized in studying DNA damage response pathways beyond canonical repair mechanisms?

Researchers should consider:

  • Replication stress responses:

    • Investigate SPCC1322.03 localization to stalled replication forks

    • Assess interactions with replisome components

    • Study recruitment dynamics following replication inhibitors

    • Analyze genetic interactions with checkpoint factors

  • Chromatin remodeling connections:

    • Examine co-localization with chromatin modifiers

    • Assess impact of histone modifications on SPCC1322.03 recruitment

    • Test interactions with chromatin remodeling complexes

    • Analyze changes in nucleosome positioning in SPCC1322.03 mutants

  • Transcriptional regulation roles:

    • Investigate potential impacts on gene expression near damage sites

    • Assess interactions with transcription factors or RNA polymerase

    • Study potential R-loop processing functions

    • Analyze transcriptional responses to DNA damage in mutants

This approach builds on methodologies used to uncover non-canonical functions of DNA repair factors in yeast .

What are the best approaches for analyzing SPCC1322.03 post-translational modifications using antibody-based techniques?

Advanced methodological approaches include:

  • Phosphorylation analysis:

    • Combine IP with phospho-specific antibodies

    • Use phosphatase treatment controls

    • Apply Phos-tag gels for mobility shift detection

    • Consider SILAC-based quantitative phosphoproteomics

  • Ubiquitination studies:

    • Perform denaturing IP to preserve modifications

    • Use tagged ubiquitin constructs as controls

    • Apply tandem ubiquitin binding entities (TUBEs) for enrichment

    • Consider targeted mass spectrometry approaches

  • Other modifications:

    • Investigate SUMOylation through specialized IP protocols

    • Assess acetylation status with modification-specific antibodies

    • Consider crosstalk between different modifications

    • Develop site-specific mutants to test functional significance

This multi-faceted approach has been effective for studying post-translational regulation of DNA repair factors .

Note: This FAQ compilation is based on current research on SPCC1322.03 and related proteins in Schizosaccharomyces pombe. As research progresses, methodologies and applications may evolve. Researchers should consult the latest literature when designing experiments.

A Practical Guide to Monoclonal Antibodies for Fission Yeast Research: SPCC1322.03 Antibody

Immunoprecipitation Protocol for Protein Interaction Studies

For effective immunoprecipitation of SPCC1322.03 and associated proteins:

  • Sample preparation:

    • Harvest 50 OD600 units of exponentially growing S. pombe cells

    • Wash cells in ice-cold PBS and resuspend in lysis buffer (50 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 10% glycerol, 0.05% NP-40, 1 mM PMSF, 1 mM DTT, 1× protease inhibitor cocktail)

    • Lyse cells using glass bead beating (5 cycles of 30 seconds beating, 1 minute cooling)

    • Clear lysate by centrifugation at 14,000 × g for 15 minutes at 4°C

  • Immunoprecipitation:

    • Pre-clear lysate with 30 μl protein A/G beads for 1 hour at 4°C

    • Add 5 μg SPCC1322.03 Antibody to pre-cleared lysate

    • Incubate overnight at 4°C with gentle rotation

    • Add 50 μl protein A/G beads and incubate for 2 hours at 4°C

    • Wash beads 4 times with lysis buffer

    • Elute proteins with SDS sample buffer or by peptide competition

  • Analysis of immunoprecipitated proteins:

    • Separate proteins by SDS-PAGE

    • Perform Western blot analysis or mass spectrometry

This protocol is based on successful approaches used for studying protein complexes in fission yeast .

Western Blot Protocol Optimization

For optimal Western blot results with SPCC1322.03 Antibody:

  • Sample preparation:

    • Extract proteins using glass bead lysis in denaturing buffer

    • Load 20-40 μg total protein per lane

    • Include positive control (wild-type extract) and negative control (deletion strain if available)

  • Gel electrophoresis and transfer:

    • Separate proteins on 8-10% SDS-PAGE

    • Transfer to PVDF membrane at 100V for 1 hour or 30V overnight

  • Antibody incubation:

    • Block membrane with 5% non-fat milk in TBST for 1 hour

    • Incubate with SPCC1322.03 Antibody at 1:1000-1:5000 dilution overnight at 4°C

    • Wash 4 times with TBST, 10 minutes each

    • Incubate with HRP-conjugated secondary antibody at 1:5000-1:10000 for 1 hour

    • Wash 4 times with TBST, 10 minutes each

  • Detection:

    • Develop using enhanced chemiluminescence

    • Expected molecular weight should be confirmed based on sequence analysis

This protocol is adapted from successful Western blot procedures for fission yeast proteins .

Chromatin Immunoprecipitation for DNA-Protein Interaction Studies

For ChIP applications with SPCC1322.03 Antibody:

  • Crosslinking and chromatin preparation:

    • Crosslink 50 ml of log-phase culture with 1% formaldehyde for 15 minutes

    • Quench with 125 mM glycine for 5 minutes

    • Wash cells with cold PBS

    • Lyse cells in ChIP lysis buffer using glass beads

    • Sonicate chromatin to 200-500 bp fragments

  • Immunoprecipitation:

    • Pre-clear chromatin with protein A/G beads

    • Add 5 μg SPCC1322.03 Antibody

    • Incubate overnight at 4°C

    • Add protein A/G beads and incubate for 2 hours

    • Wash with low salt, high salt, LiCl, and TE buffers

  • DNA recovery and analysis:

    • Reverse crosslinks at 65°C overnight

    • Treat with RNase A and Proteinase K

    • Purify DNA using phenol-chloroform extraction or column purification

    • Analyze by qPCR or sequencing

This protocol is based on methodologies used for studying chromatin-associated factors in yeast .

Quantitative Analysis of Protein Levels

For accurate quantification of SPCC1322.03 expression:

  • Western blot quantification:

    • Use a dilution series to establish a linear range of detection

    • Include housekeeping protein controls (e.g., α-tubulin, GAPDH)

    • Analyze band intensities using image analysis software

    • Normalize target protein to loading control

  • Statistical considerations:

    • Perform at least three biological replicates

    • Use appropriate statistical tests (t-test, ANOVA)

    • Report mean values with standard deviation or standard error

  • Experimental conditions that may affect expression:

    • Cell cycle stage (synchronize cultures if necessary)

    • DNA damage treatment (UV, MMS, hydroxyurea)

    • Growth phase and nutrient conditions

    • Temperature-sensitive mutations or stress conditions

This approach aligns with quantitative analysis methods used in studies of DNA repair proteins .

Analysis of Protein-Protein Interactions

For interpretation of interaction data:

  • Confirmation criteria for interactions:

    • Reproducibility across multiple experiments

    • Reciprocal co-immunoprecipitation

    • Absence in negative controls

    • Correlation with functional data

  • Interaction strength assessment:

    • Compare relative band intensities in co-IP Western blots

    • Consider stoichiometry through quantitative mass spectrometry

    • Test interaction stability under varying salt concentrations

    • Evaluate dependency on DNA/RNA through nuclease treatments

  • Functional validation approaches:

    • Test mutants disrupting predicted interaction surfaces

    • Assess phenotypic consequences of disrupting interactions

    • Map minimal interaction domains

    • Perform in vitro binding assays with purified components

This comprehensive approach was successful in characterizing the PXD complex interactions .

Common Issues and Solutions in Immunoprecipitation

IssuePossible CausesSolutions
Poor protein yieldInsufficient antibodyIncrease antibody amount to 5-10 μg
Inefficient cell lysisOptimize bead beating cycles
Protein degradationAdd additional protease inhibitors
Non-specific bindingInsufficient washingIncrease wash stringency with higher salt
Cross-reactivityPre-clear lysate with beads alone
Sticky protein propertiesAdd 0.1% BSA to wash buffer
No interaction detectedBuffer incompatibilityTest different buffer conditions
Transient interactionConsider crosslinking before lysis
Epitope masking in complexTry different antibody or tag-based approach

These troubleshooting approaches have been effective in optimizing immunoprecipitation of fission yeast proteins .

Western Blot Troubleshooting

IssuePossible CausesSolutions
No signalInsufficient proteinIncrease loading amount
Inefficient transferOptimize transfer conditions for protein size
Antibody dilution too highTest lower dilutions (1:500)
High backgroundInsufficient blockingExtend blocking time or change blocking agent
Antibody concentration too highIncrease dilution factor
Non-specific bindingAdd 0.1% Tween-20 to antibody solution
Multiple bandsPost-translational modificationsVerify with phosphatase treatment
Cross-reactivityValidate with knockout controls
Protein degradationAdd additional protease inhibitors

These approaches have been successfully applied to optimize Western blotting for various antibodies in yeast systems .

Combining SPCC1322.03 Antibody with Advanced Microscopy

Innovative approaches include:

  • Super-resolution microscopy applications:

    • Optimize sample preparation for STORM or PALM imaging

    • Combine with DNA damage markers for co-localization studies

    • Use appropriate fluorophore-conjugated secondary antibodies

    • Consider multi-color imaging for complex localization studies

  • Live cell imaging strategies:

    • Compare antibody staining with fluorescent protein tags

    • Validate key findings using orthogonal approaches

    • Analyze protein dynamics in response to DNA damage

    • Consider microfluidic systems for controlling environmental conditions

  • Correlative light and electron microscopy:

    • Use immunogold labeling for electron microscopy

    • Confirm subcellular localization at ultrastructural level

    • Analyze chromatin association in different functional states

These approaches build on imaging methods used for studying DNA repair factors .

Integration with Genomic and Proteomic Datasets

For comprehensive understanding of SPCC1322.03 function:

  • Multi-omics integration strategies:

    • Combine ChIP-seq with RNA-seq data to link binding to expression

    • Integrate proteomics data to map interaction networks

    • Correlate with genetic interaction screens

    • Develop computational models of functional relationships

  • Comparative analysis approaches:

    • Compare data across multiple yeast species

    • Analyze conservation of functions in higher eukaryotes

    • Identify shared and divergent mechanisms

    • Map evolutionary trajectories of protein functions

  • Functional prediction methods:

    • Use machine learning to predict potential functions

    • Apply structural modeling to predict interaction interfaces

    • Develop testable hypotheses for experimental validation

    • Consider systems biology approaches to map pathway interactions

This integrative approach has proven valuable in understanding complex biological functions in model organisms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.